82VS

InvestorScreen: DoneContacts: To Do

AI Sector Summary

82VS is a dedicated biotech venture studio focused on building and funding early-stage drug discovery companies, specifically in antibody therapeutics, bispecifics, and genetic medicines.

Location

Boston, Massachusetts, United States

Industry

Venture Capital and Private Equity Principals

Investor Type

venture capital

Target Sectors

biotechnology, healthcare

Verticals

Healthcare

Financials

Revenue

—

EBITDA

—

Employees

Founded

—

Sectors (from search)

healthcare · biotechnology, drug discovery, antibodies, bispecifics, TCR mimics, genetic medicines, therapeutics

Classify Status

Done

Prospects

0 people

No prospects linked to this account.

Outreach History

Outreach sequencing tables are not yet in Supabase.